2011-05-16 |
Clinical Trial Heberbiovac HB vaccine Material Reference Batch |
CIGB |
Registered |
2011-05-16 |
NASVAC therapeutic vaccine study |
CIGB |
Registered |
2011-05-16 |
Heberprovac Study |
CIGB |
Registered |
2011-05-16 |
TS-FARMEV Study |
CIGB |
Registered |
2011-05-17 |
CERVISEG-300-I Study |
CIGB |
Registered |
2011-04-28 |
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study. |
CIGB |
Registered |
2011-04-29 |
CENTAURO Study |
CIGB |
Registered |
2011-04-29 |
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months. |
CIGB |
Registered |
2011-04-30 |
NEUVITAL V Study |
CIGB |
Registered |
2011-04-30 |
Change in Manufacture Process of Heberbiovac HB vaccine. |
CIGB |
Registered |
2011-04-27 |
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. |
CIGB |
Registered |
2010-12-20 |
CIGB500 in healthy volunteers |
CIGB |
Registered |
2010-12-20 |
THERESA-2 Study |
CIGB |
Registered |
2008-10-07 |
THERESA |
CIGB |
Registered |
2009-02-27 |
Safety and immunogenicity of commercial Hepatitis B vaccines. |
CIGB |
Registered |
2010-12-20 |
Dynamic-I |
CIGB |
Registered |
2008-10-07 |
FarmaPEG-I |
CIGB |
Registered |
2010-12-20 |
Dermosep-I |
CIGB |
Registered |
2010-12-20 |
EPANEM-III |
CIGB |
Registered |
2010-12-20 |
AntiCEA M3-I |
CIGB |
Registered |